Free Trial

DENTSPLY SIRONA (XRAY) Stock Price, News & Analysis

DENTSPLY SIRONA logo
$12.96 -0.27 (-2.04%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$13.06 +0.09 (+0.73%)
As of 08/8/2025 07:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About DENTSPLY SIRONA Stock (NASDAQ:XRAY)

Key Stats

Today's Range
$12.62
$13.28
50-Day Range
$12.96
$16.85
52-Week Range
$12.16
$27.48
Volume
7.39 million shs
Average Volume
4.03 million shs
Market Capitalization
$2.59 billion
P/E Ratio
N/A
Dividend Yield
4.94%
Price Target
$18.64
Consensus Rating
Hold

Company Overview

DENTSPLY SIRONA Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
98th Percentile Overall Score

XRAY MarketRank™: 

DENTSPLY SIRONA scored higher than 98% of companies evaluated by MarketBeat, and ranked 27th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    DENTSPLY SIRONA has received a consensus rating of Hold. The company's average rating score is 2.15, and is based on 2 buy ratings, 11 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    DENTSPLY SIRONA has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about DENTSPLY SIRONA's stock forecast and price target.
  • Earnings Growth

    Earnings for DENTSPLY SIRONA are expected to grow by 3.26% in the coming year, from $1.84 to $1.90 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of DENTSPLY SIRONA is -2.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of DENTSPLY SIRONA is -2.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    DENTSPLY SIRONA has a PEG Ratio of 0.80. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    DENTSPLY SIRONA has a P/B Ratio of 1.33. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.96% of the float of DENTSPLY SIRONA has been sold short.
  • Short Interest Ratio / Days to Cover

    DENTSPLY SIRONA has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in DENTSPLY SIRONA has recently increased by 23.85%, indicating that investor sentiment is decreasing significantly.
  • Dividend Leadership

    DENTSPLY SIRONA is a leading dividend payer. It pays a dividend yield of 4.94%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    DENTSPLY SIRONA has been increasing its dividend for 13 years.

  • Dividend Sustainability

    Based on earnings estimates, DENTSPLY SIRONA will have a dividend payout ratio of 33.68% next year. This indicates that DENTSPLY SIRONA will be able to sustain or increase its dividend.

  • Read more about DENTSPLY SIRONA's dividend.
  • Percentage of Shares Shorted

    3.96% of the float of DENTSPLY SIRONA has been sold short.
  • Short Interest Ratio / Days to Cover

    DENTSPLY SIRONA has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in DENTSPLY SIRONA has recently increased by 23.85%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    DENTSPLY SIRONA has a news sentiment score of 0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 25 news articles for DENTSPLY SIRONA this week, compared to 12 articles on an average week.
  • Search Interest

    2 people have searched for XRAY on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, DENTSPLY SIRONA insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.52% of the stock of DENTSPLY SIRONA is held by insiders.

  • Percentage Held by Institutions

    95.70% of the stock of DENTSPLY SIRONA is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about DENTSPLY SIRONA's insider trading history.
Receive XRAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DENTSPLY SIRONA and its competitors with MarketBeat's FREE daily newsletter.

XRAY Stock News Headlines

Dentsply Sirona Maintains Outlook Despite Sales Decline
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.
DENTSPLY SIRONA Inc. (XRAY) Q2 2025 Earnings Call Transcript
Dentsply Sirona Reports Second Quarter 2025 Results
See More Headlines

XRAY Stock Analysis - Frequently Asked Questions

DENTSPLY SIRONA's stock was trading at $18.98 at the beginning of 2025. Since then, XRAY stock has decreased by 31.7% and is now trading at $12.96.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) issued its earnings results on Thursday, August, 7th. The medical instruments supplier reported $0.52 EPS for the quarter, topping the consensus estimate of $0.50 by $0.02. The business's revenue was down 4.9% compared to the same quarter last year.
Read the conference call transcript
.

DENTSPLY SIRONA's Board of Directors authorized a stock repurchase plan on Thursday, November 9th 2023, which authorizes the company to repurchase $1,000,000,000 in shares, according to EventVestor. This means that the company could buy up to 16.9% of its shares through open market purchases. Shares buyback plans are often a sign that the company's board believes its shares are undervalued.

The following companies are subsidiaries of DENTSPLY SIRONA: Propel Orthodontics LLC, Datum Dental Ltd., Straight Smile LLC, OraMetrix Inc, Recherche Techniques Dentaires, MIS Implants Technologies Ltd, Sirona Dental System, and others.

DENTSPLY SIRONA's top institutional shareholders include First Eagle Investment Management LLC (7.12%), Cooke & Bieler LP (4.59%), Geode Capital Management LLC (1.81%) and Bank of New York Mellon Corp (1.06%). Insiders that own company stock include Cord Friedrich Staehler, Gregory T Lucier, Glenn Coleman and Eric Brandt.
View institutional ownership trends
.

Shares of XRAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that DENTSPLY SIRONA investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Exxon Mobil (XOM).

Company Calendar

Record date for 7/11 Dividend
6/27/2025
Ex-Dividend for 7/11 Dividend
6/27/2025
Dividend Payable
7/11/2025
Last Earnings
8/07/2025
Today
8/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:XRAY
CIK
818479
Employees
14,000
Year Founded
1899

Price Target and Rating

High Price Target
$24.00
Low Price Target
$14.00
Potential Upside/Downside
+43.8%
Consensus Rating
Hold
Rating Score (0-4)
2.15
Research Coverage
13 Analysts

Profitability

EPS (Trailing Twelve Months)
($4.54)
Trailing P/E Ratio
N/A
Forward P/E Ratio
7.04
P/E Growth
0.92
Net Income
-$910 million
Net Margins
-25.85%
Pretax Margin
-30.24%
Return on Equity
16.33%
Return on Assets
5.60%

Debt

Debt-to-Equity Ratio
1.13
Current Ratio
1.69
Quick Ratio
0.76

Sales & Book Value

Annual Sales
$3.79 billion
Price / Sales
0.68
Cash Flow
$7.36 per share
Price / Cash Flow
1.76
Book Value
$9.84 per share
Price / Book
1.32

Miscellaneous

Outstanding Shares
199,290,000
Free Float
198,297,000
Market Cap
$2.58 billion
Optionable
Optionable
Beta
0.94

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:XRAY) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners